October 30: The Week in Cancer News
The U.S. Preventive Services Task Force suggests the age people should begin routine colorectal cancer screening should be lowered, and more news of the week from Cancer Today.
Progress Against Cancer
The U.S. Preventive Services Task Force suggests the age people should begin routine colorectal cancer screening should be lowered, and more news of the week from Cancer Today.
A newly discovered set of salivary glands could have implications for head and neck cancer patients, and more news of the week from Cancer Today.
Study results show importance of considering age of the patient in cancer treatment.
The 2020 Nobel Prize in Chemistry was awarded to Fellows of the AACR Academy Emmanuelle Charpentier, PhD, and Jennifer A. Doudna, PhD, for their groundbreaking development of the CRISPR-Cas9 genome editing system. This technology allows researchers to accurately delete, add, or modify specific regions of the genome and has proven to be valuable across various fields of research, including...
Unexpected expenses may deter people from undergoing colonoscopies, and more news of the week from Cancer Today.
A study finds that more than half of cancer patients participate in clinical trials when asked.
A new study reports that an inexpensive way to analyze DNA isolated from cells in urine is more sensitive than urine cytology, a microscopic examination of cells in the urine. When a doctor suspects...
A study of 1.7 million women finds that HPV vaccination reduces the rate of cervical cancer.
The FDA approved a combination of two immune checkpoint inhibitors to treat adult patients with unresectable malignant pleural mesothelioma.
Long-term social and economic factors contribute to disparities in cancer mortality in U.S. counties with "persistent poverty".
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More